Epidemiology and Management of Metastatic Breast Cancer
This is a multicenter, national, retrospective chart-review study that will be based on the collection of data from electronical or paper-based medical records with available data on female patients diagnosed with metastatic brest cancer . The main purpose of this study is to provide accurate, evidence based description on the incidence of progression of metastatic breast cancer and its clinical management.
Breast Cancer Nos Metastatic Recurrent
The incidence rate of progression of disease in a cohort of patients newly diagnosed with MBC, either De Novo or having progressed from a non-metastatic stage, At 12 and 18 months after diagnosis
The progression free survival (PFS) rates, At 12 and 18 months after diagnosis|The progression free survival (PFS) time, At 18 months after diagnosis|Time to progression (TTP), At 18 months after diagnosis|The clinical and pathological characteristics of newly diagnosed MBC patients, At 18 months after diagnosis|The socio-demographic and anthropometric characteristics of newly diagnosed MBC patients, At 18 months after diagnosis|Health care utilization associated with the disease in Romania, At 18 months after diagnosis
Epidemiology and Therapeutic Management of Metastatic Breast Cancer in Romania: A retrospective cohort study